DerrickWayneSpellMDFACP

Oncology • Baton Rouge, LA

Breast Cancer

Partner at Louisiana Hematology Oncology Associates

Join to view full profile

Dr. Spell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Spell's full profile

Already have an account?

Office
Mary Bird Perkins Cancer Center
4950 Essen Lane Suite 500
Baton Rouge, LA 70809
Phone+1 225-767-1311

Fax+1 225-214-6759

Summary

Dr. Derrick Spell is an oncologist in Baton Rouge, LA and is affiliated with Woman's Hospital. He received his medical degree from Louisiana State University School of Medicine in New Orleans and has been in practice 25 years. He specializes in breast cancer and is experienced in breast cancer, multidisciplinary cancer care, and neoadjuvant cancer treatments.

Home | Derrick W. Spell, MD

The Bite-Sized Guide to Getting Right-Sized Now available at Barnes & Noble and for Nook! Also available at Amazon and for Kindle! How did I achieve and sustain

Education & Training

University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2000 - 2002
Louisiana State University School of Medicine (Baton Rouge)Residency, Internal Medicine, 1997 - 2000
Louisiana State University School of Medicine in New OrleansClass of 1997

Certifications & Licensure

LA State Medical License 1998 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

QOPI Certified Practice American Society of Clinical Oncology, 2010-2020
Best Doctor Best Doctors, 2007-2020
District 1 School Board Member East Baton Rouge Parish Schools, 2007-2010
Fellow American College of Physicians, 2008
Top 40 Under 40 Baton Rouge Business Report, 2006
Join now to see all

Clinical Trials

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Start of enrollment: 2015 Mar 25
Active, not recruiting
Not Applicable
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy Start of enrollment: 2015 Oct 20
Active, not recruiting
Phase 3
Breast Cancer WEight Loss Study (BWEL Study) Start of enrollment: 2016 Aug 01
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

109 citations
The value of a complete blood count in predicting cancer of the colon
Derrick W. Spell, Dennie V. Jones, William F Harper, J. David Bessman
Cancer Detection and Prevention. 2004-01-01
16 citations
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Shinn-Huey S Chou, Justin Romanoff, Constance D Lehman, Seema A Khan, Ruth Carlos
Radiology. 2021-10-01
18 citations
Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment
Constance D. Lehman, Constantine Gatsonis, Justin Romanoff, Seema A. Khan, Ruth C. Carlos
JAMA Oncology. 2019-07-01

Authored Content

The Bite-Sized Guide to Getting Right-SizedFebruary 2019

Press Mentions

When He Popped the Button on His Coat, Dr. Derrick Spell Knew It Was Time to Lose Weight. 80 Pounds Later, He Explains How in His New BookAugust 11th, 2019
Louisiana Hematology Oncology Associates Recertified for Cancer CareMarch 27th, 2017
Abstract p3-02-12: Impact of Magnetic Resonance Imaging on Conversion from Wide Local Excision to Mastectomy in Patients with Ductal Carcinoma in Situ: First Results from the ECOG-ACRIN 4112 Prospective StudyFebruary 20th, 2017

Committees

Member, Woman's Hospital Breast Cancer Leadership Team 2009 - Present
Member, Woman's Hospital Institutional Review Board 2007 - Present
Member, Our Lady of the Lake Colorectal Cancer Multidisciplinary Team 2008 - 2012